Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
R&D
Pharma
It may be a tough slog for biotechs after Biden bill: Amgen CEO
In an era of abundant pharma buyouts, small and midsized biotechs may find it increasingly difficult to go their own way, Amgen's CEO said.
Fraiser Kansteiner
Sep 15, 2022 12:55pm
AZ's R&D chiefs talk roxadustat, Imfinzi-treme
Feb 10, 2022 10:13am
BioNTech is taking over a Kite Pharma cell therapy plant in MD
Jul 19, 2021 11:01am
Pandemic will make 'steady as you go' a risky strategy: report
May 21, 2021 11:57am
Lilly, BMS lead innovation and invention in pharma: study
Apr 22, 2021 11:08am
Shanghai Pharma maps $1.18B construction project in hometown hub
Jan 5, 2021 7:43am
